These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34412102)

  • 21. Pharmacogenetic testing in the Veterans Health Administration (VHA): policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee.
    Vassy JL; Stone A; Callaghan JT; Mendes M; Meyer LJ; Pratt VM; Przygodzki RM; Scheuner MT; Wang-Rodriguez J; Schichman SA;
    Genet Med; 2019 Feb; 21(2):382-390. PubMed ID: 29858578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and regulatory considerations in pharmacogenetic testing.
    Schuck RN; Marek E; Rogers H; Pacanowski M
    Am J Health Syst Pharm; 2016 Dec; 73(23):1999-2006. PubMed ID: 27864207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines.
    Abdullah-Koolmees H; van Keulen AM; Nijenhuis M; Deneer VHM
    Front Pharmacol; 2020; 11():595219. PubMed ID: 33568995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.
    Caudle KE; Sangkuhl K; Whirl-Carrillo M; Swen JJ; Haidar CE; Klein TE; Gammal RS; Relling MV; Scott SA; Hertz DL; Guchelaar HJ; Gaedigk A
    Clin Transl Sci; 2020 Jan; 13(1):116-124. PubMed ID: 31647186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetic testing in oncology: a Brazilian perspective.
    Suarez-Kurtz G
    Clinics (Sao Paulo); 2018 Oct; 73(suppl 1):e565s. PubMed ID: 30328952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe.
    Lu M; Lewis CM; Traylor M
    BMC Med Genomics; 2017 Jun; 10(1):47. PubMed ID: 28629370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenomic biomarker information on drug labels of the Spanish Agency of Medicines and Sanitary products: evaluation and comparison with other regulatory agencies.
    Estévez-Paredes M; Mata-Martín MC; de Andrés F; LLerena A
    Pharmacogenomics J; 2024 Jan; 24(1):2. PubMed ID: 38233388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A survey of physician opinions in Russia in the field of pharmacogenetics of cardiovascular disease.
    Sychev D; Fedina L; Poptsova M; Zateyshchikov D; Mirzaev K; Tsimbal E; Sychev I; Rastvorova T
    Pharmacogenomics; 2022 Oct; 23(15):847-856. PubMed ID: 36093937
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacogenomics in Pain Management: A Review of Relevant Gene-Drug Associations and Clinical Considerations.
    Brandl E; Halford Z; Clark MD; Herndon C
    Ann Pharmacother; 2021 Dec; 55(12):1486-1501. PubMed ID: 33771051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetic Testing: Why Is It So Disappointing?
    Limandri BJ
    J Psychosoc Nurs Ment Health Serv; 2019 Apr; 57(4):9-12. PubMed ID: 30933297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Value of Pharmacogenetics to Reduce Drug-Related Toxicity in Cancer Patients.
    Mhandire DZ; Goey AKL
    Mol Diagn Ther; 2022 Mar; 26(2):137-151. PubMed ID: 35113367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
    Luzum JA; Pakyz RE; Elsey AR; Haidar CE; Peterson JF; Whirl-Carrillo M; Handelman SK; Palmer K; Pulley JM; Beller M; Schildcrout JS; Field JR; Weitzel KW; Cooper-DeHoff RM; Cavallari LH; O'Donnell PH; Altman RB; Pereira N; Ratain MJ; Roden DM; Embi PJ; Sadee W; Klein TE; Johnson JA; Relling MV; Wang L; Weinshilboum RM; Shuldiner AR; Freimuth RR;
    Clin Pharmacol Ther; 2017 Sep; 102(3):502-510. PubMed ID: 28090649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated Pharmacogenomic Reports for Clinical Genome Sequencing.
    Klanderman BJ; Koch C; Machini K; Parpattedar SS; Bandyadka S; Lin CF; Hynes E; Lebo MS; Amr SS
    J Mol Diagn; 2022 Mar; 24(3):205-218. PubMed ID: 35041930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC
    Blazy C; Ellingrod V; Ward K
    Front Pharmacol; 2022; 13():939313. PubMed ID: 35814245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
    Wellmann R; Borden BA; Danahey K; Nanda R; Polite BN; Stadler WM; Ratain MJ; O'Donnell PH
    Cancer; 2018 Jul; 124(14):3052-3065. PubMed ID: 29742281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.
    Quaranta S; Dupouey J; Colle R; Verstuyft C
    Therapie; 2017 Apr; 72(2):311-318. PubMed ID: 28237405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics of immunosuppressants: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics (RNPGx).
    Woillard JB; Chouchana L; Picard N; Loriot MA;
    Therapie; 2017 Apr; 72(2):285-299. PubMed ID: 28318610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression.
    Rothschild AJ; Parikh SV; Hain D; Law R; Thase ME; Dunlop BW; DeBattista C; Conway CR; Forester BP; Shelton RC; Macaluso M; Brown K; Lewis D; Gutin A; Jablonski MR; Greden JF
    Psychiatry Res; 2021 Feb; 296():113649. PubMed ID: 33360967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenomic biomarker information differences between drug labels in the United States and Hungary: implementation from medical practitioner view.
    Varnai R; Szabo I; Tarlos G; Szentpeteri LJ; Sik A; Balogh S; Sipeky C
    Pharmacogenomics J; 2020 Jun; 20(3):380-387. PubMed ID: 31787752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.